STANDARD BIOTOOLS INC.·4

Feb 23, 9:45 PM ET

Davis Jeremy Steven 4

4 · STANDARD BIOTOOLS INC. · Filed Feb 23, 2023

Insider Transaction Report

Form 4
Period: 2023-02-21
Davis Jeremy Steven
SVP Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-21+20,83320,833 total
  • Tax Payment

    Common Stock

    2023-02-21$2.03/sh6,176$12,53714,657 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-02-2120,833229,167 total
    Common Stock (20,833 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
  • [F2]On December 20, 2022, the Reporting Person was granted 250,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.

Documents

1 file
  • 4
    wf-form4_167720668432890.xmlPrimary

    FORM 4